ASIC approves C3 name change

By Dylan Bushell-Embling
Tuesday, 17 June, 2008

The Australian Securities and Investments Commission (ASIC) has approved the request by Clinical Cell Culture (ASX: CCE) to rename itself Avita Medical.

The name change will take effect on June 26, when Avita will begin trading on the ASX under the code AVH.

Farm animals and aquaculture cryopreservation partnership announced

Vitrafy Life Sciences Limited has announced that it has entered a 12-month exclusive agreement...

Babies of stressed mothers likely to get their teeth earlier

Maternal stress during pregnancy can speed up the timing of teeth eruption, which may be an early...

Customised immune cells used to fight brain cancer

Researchers have developed CAR-T cells — ie, genetically modified immune cells manufactured...

Content from other channels on our network

Carbon-conversion technology creates chemicals for jet fuel

Novel energy storage system to decarbonise buildings

F-Gas Regulation: Turning necessity into opportunity

Tiny gold spheres could improve solar energy harvesting

Methane reduction trial uses nature-based supplement

Afnor acquires HACCP Australia and HACCP International

Solving the limitations for paper packaging with coating strategy

Packserv expands into the US with its packaging machinery

Keeping PEZ tablets rolling consistently with print upgrade

Food-grade upscaling line for 'new food' developments

REDFEB highlights the impacts of chronic stress on the heart

Teachers Health Group announces Simone Tregeagle as next CEO

Pathways to proof: could this transcranial treatment ease chronic pain?

New public hospital funding deal "will not be enough", doctors warn

St Vincent's Hospital faces two charges after patient death